###begin article-title 0
Distinct versus overlapping functions of MDC1 and 53BP1 in DNA damage response and tumorigenesis
###end article-title 0
###begin p 1
###xml 31 51 31 51 <email xmlns:xlink="http://www.w3.org/1999/xlink">Junjie.Chen@yale.edu</email>
###xml 69 89 69 89 <email xmlns:xlink="http://www.w3.org/1999/xlink">Lou.Zhenkun@mayo.edu</email>
###xml 81 85 <span type="species:ncbi:162683">mayo</span>
Correspondence to Junjie Chen: Junjie.Chen@yale.edu; or Zhenkun Lou: Lou.Zhenkun@mayo.edu
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 508 512 <span type="species:ncbi:10090">mice</span>
The importance of the DNA damage response (DDR) pathway in development, genomic stability, and tumor suppression is well recognized. Although 53BP1 and MDC1 have been recently identified as critical upstream mediators in the cellular response to DNA double-strand breaks, their relative hierarchy in the ataxia telangiectasia mutated (ATM) signaling cascade remains controversial. To investigate the divergent and potentially overlapping functions of MDC1 and 53BP1 in the ATM response pathway, we generated mice deficient for both genes. Unexpectedly, the loss of both MDC1 and 53BP1 neither significantly increases the severity of defects in DDR nor increases tumor incidence compared with the loss of MDC1 alone. We additionally show that MDC1 regulates 53BP1 foci formation and phosphorylation in response to DNA damage. These results suggest that MDC1 functions as an upstream regulator of 53BP1 in the DDR pathway and in tumor suppression.
###end p 3
###begin p 4
###xml 242 247 <span type="species:ncbi:10090">mouse</span>
Abbreviations used in this paper: ATM, ataxia telangiectasia mutated; BRCT, BRCA1 C terminal; CSR, class-switch recombination; DDR, DNA damage response; DKO, double KO; HR, homologous recombination; IR, ionizing radiation; KO, knockout; MEF, mouse embryonic fibroblast; MMC, mitomycin C; WT, wild type.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 317 330 317 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">Abraham, 2001</xref>
###xml 633 645 633 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">Shiloh, 2003</xref>
###xml 709 731 709 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">Xu and Baltimore, 1996</xref>
###xml 733 748 733 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">Xu et al., 1996</xref>
###xml 451 459 <span type="species:ncbi:9606">patients</span>
###xml 667 671 <span type="species:ncbi:10090">mice</span>
To ensure the meticulous transmission of genetic information, there exists a series of checkpoints that are activated when DNA damage is detected. At the apex of the signaling cascade initiated after the detection of DNA double-strand breaks is the serine/threonine protein kinase ataxia telangiectasia mutated (ATM; Abraham, 2001). ATM has been shown to phosphorylate a broad range of substrates upon activation, including NBS1, BRCA1, and Chk2. ATM patients show symptoms including neural degeneration, immunodeficiency, growth retardation, premature aging, cancer predisposition, and severe sensitivity to ionizing radiation (IR; Shiloh, 2003), with ATM-deficient mice displaying many of these phenotypes (Xu and Baltimore, 1996; Xu et al., 1996). Thus, understanding the ATM signaling cascade has been pivotal to discovering the mechanisms underlying genomic instability and tumorigenesis. Recently, 53BP1 and MDC1 have been recognized as critical upstream mediators in the cellular response to double-strand breaks, although the extent and nature of their interaction is not known.
###end p 6
###begin p 7
###xml 333 351 333 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">Huyen et al., 2004</xref>
###xml 449 469 449 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">Schultz et al., 2000</xref>
###xml 471 492 471 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">Anderson et al., 2001</xref>
###xml 494 514 494 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">Rappold et al., 2001</xref>
###xml 605 637 605 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">Fernandez-Capetillo et al., 2002</xref>
###xml 639 656 639 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">Wang et al., 2002</xref>
###xml 756 776 756 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">Morales et al., 2003</xref>
###xml 778 795 778 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">Ward et al., 2003</xref>
###xml 126 131 <span type="species:ncbi:4932">yeast</span>
###xml 691 695 <span type="species:ncbi:10090">mice</span>
###xml 808 812 <span type="species:ncbi:10090">mice</span>
53BP1 has been suggested to be the mammalian orthologue of scRad9/spCrb2, a protein critical for DNA damage response (DDR) in yeast. Like many proteins of the DDR pathways, 53BP1 contains tandem BRCA1 C-terminal (BRCT) domains. In addition, 53BP1 contains a tudor domain that binds methylated K79 of histone H3 or K20 of histone H4 (Huyen et al., 2004). 53BP1 is phosphorylated after IR in an ATM-dependent fashion and localizes to IR-induced foci (Schultz et al., 2000; Anderson et al., 2001; Rappold et al., 2001). Furthermore, moderate checkpoint defects have been reported in cells depleted of 53BP1 (Fernandez-Capetillo et al., 2002; Wang et al., 2002). Analysis of 53BP1 knockout (KO) mice confirmed an important role for 53BP1 in genomic stability (Morales et al., 2003; Ward et al., 2003), with null mice recapitulating some of the ATM-deficient phenotypes, although they were less severe (notably growth retardation, mild checkpoint defect, genomic instability, and mild tumor incidence). These moderate phenotypes challenge the notion that 53BP1 is the only orthologue of the original scRad9.
###end p 7
###begin p 8
###xml 103 127 103 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">Stucki and Jackson, 2004</xref>
###xml 404 423 400 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">Stucki et al., 2005</xref>
###xml 425 441 421 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">Lou et al., 2006</xref>
###xml 576 600 572 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">Stucki and Jackson, 2004</xref>
###xml 660 676 656 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">Lou et al., 2004</xref>
###xml 678 696 674 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">Zhang et al., 2005</xref>
###xml 848 864 844 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">Lou et al., 2006</xref>
###xml 1197 1200 1193 1196 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1234 1237 1230 1233 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 733 737 <span type="species:ncbi:10090">mice</span>
###xml 877 881 <span type="species:ncbi:10090">mice</span>
###xml 1201 1205 <span type="species:ncbi:10090">mice</span>
###xml 1238 1242 <span type="species:ncbi:10090">mice</span>
Subsequently, MDC1 was identified and described by several groups as being a critical mediator of DDR (Stucki and Jackson, 2004). MDC1 contains tandem BRCT domains as well as a forkhead-associated domain and a repeat region, which also mediate protein interactions. Through its BRCT domains, MDC1 binds gammaH2AX and recruits activated ATM to the sites of DNA damage, thus amplifying DNA damage signals (Stucki et al., 2005; Lou et al., 2006). siRNA against MDC1 were used to demonstrate MDC1's role in G2/M checkpoint response, IR-induced foci formation, and Chk2 signaling (Stucki and Jackson, 2004). A role of MDC1 in DNA repair has also been demonstrated (Lou et al., 2004; Zhang et al., 2005). However, it was not until MDC1 KO mice were generated that the importance of MDC1's function in ATM signaling and genomic stability became apparent (Lou et al., 2006). MDC1-null mice displayed many of the phenotypes associated with ATM deficiency: growth retardation, IR sensitivity, male infertility, gross genomic instability, and S-phase and G2/M checkpoint defects. Although it remains to be determined whether MDC1 has tumor suppressor functions in vivo, so far the phenotypes observed in MDC1-/- mice are milder than those of ATM-/- mice, suggesting that MDC1, like 53BP1, only regulates a subset of ATM signaling.
###end p 8
###begin p 9
###xml 411 429 411 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">Manis et al., 2004</xref>
###xml 431 448 431 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">Ward et al., 2004</xref>
###xml 411 416 <span type="species:ncbi:156483">Manis</span>
###xml 690 694 <span type="species:ncbi:10090">mice</span>
The data regarding the interactions between MDC1 and 53BP1 in the ATM signaling cascade have often been conflicting; although both 53BP1 and MDC1 are required for correct and robust DDR, there are some differences between the two proteins. Notably, 53BP1 does not seem to play a major role in checkpoint activation but is crucial in a subset of DNA repair functions, especially class-switch recombination (CSR; Manis et al., 2004; Ward et al., 2004). In contrast, MDC1 seems to have major role in checkpoint activation but a moderate role in DNA repair. Thus, it appears that MDC1 and 53BP1 may regulate separate branches of the DDR downstream of ATM. To clarify these points, we generated mice deficient of both MDC1 and 53BP1 and investigated how the loss of both MDC1 and 53BP1 affects DDR and tumorigenesis.
###end p 9
###begin title 10
Results and discussion
###end title 10
###begin title 11
MDC1/53BP1 deficiency and radiosensitivity
###end title 11
###begin p 12
###xml 147 169 147 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">Xu and Baltimore, 1996</xref>
###xml 171 188 171 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">Ward et al., 2003</xref>
###xml 190 206 190 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">Lou et al., 2006</xref>
###xml 326 329 326 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 339 342 339 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 388 396 388 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 493 496 493 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 514 517 514 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 899 902 899 902 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 911 914 911 914 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 944 952 944 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 978 995 978 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">Ward et al., 2003</xref>
###xml 997 1013 997 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">Lou et al., 2006</xref>
###xml 1094 1097 1094 1097 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1106 1109 1106 1109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1170 1173 1170 1173 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1197 1200 1197 1200 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 209 213 <span type="species:ncbi:10090">Mice</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 482 486 <span type="species:ncbi:10090">mice</span>
###xml 855 860 <span type="species:ncbi:10090">mouse</span>
###xml 915 919 <span type="species:ncbi:10090">mice</span>
###xml 1030 1034 <span type="species:ncbi:10090">mice</span>
###xml 1110 1114 <span type="species:ncbi:10090">mice</span>
One of the hallmarks of defective DDR is hypersensitivity to IR. ATM-, MDC1-, and 53BP1-deficient mice have been shown to be hypersensitive to IR (Xu and Baltimore, 1996; Ward et al., 2003; Lou et al., 2006). Mice deficient for both MDC1 and 53BP1 (double KO [DKO]) demonstrated similar overall levels of morbidity to the MDC1-/- and 53BP1-/- mice 12 d after 7 Gy whole body irradiation (Fig. 1 A), all of whose survival were significantly lower than the survival of wild-type (WT) mice (53BP1-/-, P = 0.0164; MDC1-/-, P = 0.0494; DKO, P = 0.0455). DKO survival after IR was distinct from that of the single KOs, as the DKO onset of morbidity was earlier than that of the single KOs, although this did not correspond with a significant decrease in survival (P = 0.4672 for MDC1 KO and P = 0.7968 for 53BP1 KO). Correlating with the whole body IR results, mouse embryonic fibroblasts (MEFs) from MDC1-/- or 53BP1-/- mice show sensitivity to IR (Fig. 1 B) as previously reported (Ward et al., 2003; Lou et al., 2006). MEFs from DKO mice are only slightly more sensitive to IR than those from MDC1-/- or 53BP1-/- mice, although not statistically more so (P = 0.668 for MDC1-/- and P = 0.439 for 53BP1-/-).
###end p 12
###begin p 13
###xml 0 38 0 38 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Radiosensitivity of DKO mice and MEFs.</bold>
###xml 78 79 78 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 91 94 91 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 96 97 96 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 108 111 108 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 113 114 113 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 131 132 131 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 197 200 197 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 206 209 206 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 376 379 376 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 385 388 385 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 24 28 <span type="species:ncbi:10090">mice</span>
###xml 138 142 <span type="species:ncbi:10090">mice</span>
Radiosensitivity of DKO mice and MEFs. (A) Kaplan-Meier survival curve of WT (n = 9), 53BP1-/- (n = 8), MDC1-/- (n = 10), and DKO (n = 8) mice after 7 Gy of whole body IR. (B) Survival of WT, 53BP1-/-, MDC1-/-, and DKO MEFs 5 d after 0, 1, and 2 Gy IR as determined by Trypan blue exclusion. Error bars represent SEM from two independent experiments. (C) Survival of WT, 53BP1-/-, MDC1-/-, and DKO MEFs 48 h after continuous treatment with the indicated amounts of MMC. Error bars represent SEM from four independent experiments.
###end p 13
###begin p 14
###xml 147 155 147 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 356 377 356 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">Brugmans et al., 2007</xref>
###xml 470 486 470 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">Xie et al., 2007</xref>
###xml 551 554 551 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 646 664 646 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">Zhang et al., 2005</xref>
###xml 666 682 666 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">Xie et al., 2007</xref>
To further confirm our IR data, we chose to test the sensitivity of these cell lines to the DNA cross-linking agent mitomycin C (MMC). As shown in Fig. 1 C, 53BP1 KO MEFs showed a mild, insignificant resistance to MMC when compared with WT (P = 0.167). MMC-induced DNA damage is believed to be mainly repaired by the homologous recombination (HR) pathway (Brugmans et al., 2007), and loss of 53BP1 has been shown to enhance HR as a result of its suppressive role in HR (Xie et al., 2007), which could contribute to this mild resistance to MMC in 53BP1-/- cells. Inversely, the loss of MDC1, which has been reported to be involved in HR pathways (Zhang et al., 2005; Xie et al., 2007), resulted in mild decreased survival in comparison to WT (P = 0.071). However, the DKO line displayed a significantly higher sensitivity to MMC than WT and 53BP1 lines (P = 0.0031 and P < 0.0001, respectively) but was not significantly more sensitive to MMC than the MDC1 KO line (P = 0.2267). This result suggests that although MDC1 and 53BP1 may have distinct repair functions, the loss of MDC1 is a dominant effect in the context of DKO.
###end p 14
###begin title 15
MDC1/53BP1 deficiency and genomic instability
###end title 15
###begin p 16
###xml 22 25 22 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 35 38 35 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 105 122 105 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">Ward et al., 2003</xref>
###xml 124 140 124 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">Lou et al., 2006</xref>
###xml 541 544 541 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 553 556 553 556 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 705 707 705 707 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;6</sup>
###xml 723 731 723 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 822 825 822 825 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 837 852 837 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, A and B</xref>
###xml 1029 1032 1029 1032 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;11</sup>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
###xml 752 756 <span type="species:ncbi:10090">mice</span>
As MEFs from both MDC1-/- and 53BP1-/- mice have been shown to have higher rates of genomic instability (Ward et al., 2003; Lou et al., 2006), we next examined how the loss of both MDC1 and 53BP1 affects chromosome stability before and after IR. Mitotic spreads prepared from single and DKO passage 1 MEFs were examined by light microscopy. Although unirradiated WT MEFs had relatively few spontaneous chromosomal aberrations (14% of MEFs examined), including chromatid breaks, chromosome fusions, and fragments from chromosome breaks, 53BP1-/- and MDC1-/- MEFs had a significantly higher incidence with 40% and 60% of spreads containing chromosome aberrations, respectively (P = 0.00019 and P = 3.35 x 10-6, respectively; Fig. 2 A). The MEFs from DKO mice displayed slightly more chromosome aberrations than those of MDC1-/- MEFs (70%; Fig. 2, A and B), which is not considered a statistically significant increase (P = 0.8) but is highly significant when compared with spontaneous breaks in WT and 53BP1 KO cells (P = 1.01 x 10-11 for WT and P = 0.00016 for 53BP1 KO).
###end p 16
###begin p 17
###xml 28 31 28 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 37 40 37 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Genomic instability in 53BP1<sup>&#8722;/&#8722;</sup>, MDC1<sup>&#8722;/&#8722;</sup>, and DKO MEFs.</bold>
###xml 302 305 302 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 341 344 341 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 376 378 376 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;6</sup>
###xml 415 418 415 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;11</sup>
Genomic instability in 53BP1-/-, MDC1-/-, and DKO MEFs. Mitotic spreads were produced as described in Materials and methods. (A) The percentage of mitotic spreads with spontaneous chromosomal abnormalities was determined by light microscopy. The asterisk denotes a significant difference from WT (53BP1-/- compared with WT, P = 0.00019; MDC1-/- compared with WT, P = 3.35 x 10-6; DKO compared with WT, P = 1.01 x 10-11). (B) Representative pictures of chromosomal aberrations from DKO MEFs. Different aberrations are indicated by colored arrows. (C) Percentage of metaphase spreads with the indicated number of DNA breaks from unirradiated or irradiated MEFs. 100 metaphase spreads/genotype were evaluated. Bar, 10 muM.
###end p 17
###begin p 18
###xml 186 194 186 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 332 335 332 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 457 460 457 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 537 540 537 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 626 629 626 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 766 773 766 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Figs. 1</xref>
###xml 778 779 778 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">2</xref>
###xml 926 930 <span type="species:ncbi:10090">mice</span>
We next examined DNA breaks caused by IR. Cells were treated with 1 Gy IR and were allowed to recover for 1 h, and spreads were made and examined for chromosome aberrations. As shown in Fig. 2 C, WT MEFs had zero to four breaks per spread, with zero being the highest frequency at 40% followed by one-break frequencies of 38%. 53BP1-/- cells had between zero and eight breaks per spread, with two and then one break per spread being the most prevalent. MDC1-/- MEFs again appear more sensitive to chromosomal aberrations than WT or 53BP1-/- and had >90% of spreads containing two or more breaks. The DKOs recapitulate the MDC1-/- phenotype more closely with a larger proportion of spreads containing two or more chromosomal abnormalities after IR. The data shown in Figs. 1 and 2 relating to IR sensitivity, DNA repair, and genomic stability suggest that the loss of MDC1 contributes to most of the phenotypes observed in DKO mice and cells.
###end p 18
###begin title 19
MDC1/53BP1 deficiency, development, and tumorigenesis
###end title 19
###begin p 20
###xml 99 102 99 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 123 138 123 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">Xu et al., 1996</xref>
###xml 146 149 146 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 178 195 178 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">Ward et al., 2003</xref>
###xml 205 208 205 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 259 262 259 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 323 339 323 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">Lou et al., 2006</xref>
###xml 398 401 398 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
###xml 350 354 <span type="species:ncbi:10090">mice</span>
###xml 402 406 <span type="species:ncbi:10090">mice</span>
We also examined how the loss of 53BP1 and MDC1 affects development and tumorigenesis. Although ATM-/- mice are infertile (Xu et al., 1996), 53BP1-/- mice show normal fertility (Ward et al., 2003), as MDC1-/- mice show an intermediate phenotype with male MDC1-/- mice being infertile and females showing reduced fertility (Lou et al., 2006). The DKO mice showed the same fertility phenotype as MDC1-/- mice (unpublished data).
###end p 20
###begin p 21
###xml 47 50 47 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 105 127 105 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">Xu and Baltimore, 1996</xref>
###xml 129 144 129 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">Xu et al., 1996</xref>
###xml 161 164 161 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 199 217 199 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">Manis et al., 2004</xref>
###xml 219 236 219 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">Ward et al., 2004</xref>
###xml 329 349 329 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">Morales et al., 2003</xref>
###xml 351 368 351 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">Ward et al., 2003</xref>
###xml 386 389 386 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 478 494 478 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">Lou et al., 2006</xref>
###xml 670 673 670 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 680 683 680 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 716 719 716 719 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 729 732 729 732 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 805 813 805 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
###xml 165 169 <span type="species:ncbi:10090">mice</span>
###xml 199 204 <span type="species:ncbi:156483">Manis</span>
###xml 390 394 <span type="species:ncbi:10090">mice</span>
###xml 693 697 <span type="species:ncbi:10090">mice</span>
###xml 733 737 <span type="species:ncbi:10090">mice</span>
###xml 799 803 <span type="species:ncbi:10090">mice</span>
We next evaluated immunological phenotypes. ATM-/- mice show defects in both CSR and T cell development (Xu and Baltimore, 1996; Xu et al., 1996). Although 53BP1-/- mice show a severe defect in CSR (Manis et al., 2004; Ward et al., 2004) and a decreased number of mature T cells, overall T cell development appears to be intact (Morales et al., 2003; Ward et al., 2003). Similarly, MDC1-/- mice show a moderate defect in CSR and no apparent abnormalities in T cell development (Lou et al., 2006). To examine whether the loss of both MDC1 and 53BP1 would result in a defect in T cell development, we stained CD4 and CD8 of lymphocytes isolated from the thymus of WT, MDC1-/-, 53BP1-/-, and DKO mice. Like that of MDC1-/- and 53BP1-/- mice, no obvious defect in T cell development was observed in DKO mice (Fig. 3 A). These results suggest that unlike ATM, MDC1 and 53BP1 are not essential for T cell development.
###end p 21
###begin p 22
###xml 61 64 61 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 0 79 0 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink">T cell development, tumor incidence, and spectrum in WT, MDC1<sup>&#8722;/&#8722;</sup>, and DKO mice.</bold>
###xml 109 112 109 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 119 122 119 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 266 267 266 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 279 282 279 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 284 285 284 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 302 303 302 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 424 427 424 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 468 470 468 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;6</sup>
###xml 525 527 525 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;9</sup>
###xml 595 598 595 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
###xml 310 314 <span type="species:ncbi:10090">mice</span>
###xml 428 432 <span type="species:ncbi:10090">mice</span>
###xml 450 454 <span type="species:ncbi:10090">mice</span>
###xml 489 493 <span type="species:ncbi:10090">mice</span>
###xml 607 611 <span type="species:ncbi:10090">mice</span>
T cell development, tumor incidence, and spectrum in WT, MDC1-/-, and DKO mice. (A) Lymphocytes from WT, MDC1-/-, 53BP1-/-, and DKO mice. Numbers in each quadrant indicate percentage of the total population. (B and C) Spontaneous tumor incidence and spectrum in WT (n = 19), MDC1-/- (n = 20), and DKO (n = 27) mice for up to 21 mo were determined. The asterisk denotes significant difference from WT (tumor incidence in MDC1-/- mice compared with WT mice, P = 7.6 x 10-6; incidence in DKO mice compared with WT, P = 1.26 x 10-9). (D) Representative pictures of lymphoma and lung cancer from MDC1-/- and DKO mice.
###end p 22
###begin p 23
###xml 60 63 60 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 153 156 153 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 192 200 192 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 242 245 242 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 360 375 360 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, C and D</xref>
###xml 701 709 701 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 91 95 <span type="species:ncbi:10090">mice</span>
###xml 157 161 <span type="species:ncbi:10090">mice</span>
###xml 246 250 <span type="species:ncbi:10090">mice</span>
Finally, we examined spontaneous tumor incidence in WT, MDC1-/-, and DKO mice. 10.5% of WT mice developed tumors by the age of 21 mo, whereas 25% of MDC1-/- mice developed tumors (P = 0.0001; Fig. 3 B). The majority of tumors from WT and MDC1-/- mice are lymphomas, which also metastasized to other organs, such as the lung, liver, and gastrointestinal tract (Fig. 3, C and D). These results are the first to demonstrate that MDC1 acts as a tumor suppressor, suggesting that genomic instability caused by the loss of MDC1 does contribute to tumorigenesis. However, the loss of both 53BP1 and MDC1 only resulted in a mild increase in tumor incidence in comparison to the loss of MDC1 alone (P = 0.356; Fig. 3 B).
###end p 23
###begin title 24
53BP1 and MDC1 in the DNA damage signaling pathway
###end title 24
###begin p 25
###xml 102 121 102 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">Mochan et al., 2003</xref>
###xml 146 149 146 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 156 159 156 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 217 237 217 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">Mochan et al. (2003)</xref>
###xml 375 383 375 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 534 542 534 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 722 730 722 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
A previous study using siRNAs suggests that MDC1 and 53BP1 work in parallel pathways to activate ATM (Mochan et al., 2003). We used MEFs from MDC1-/-, 53BP1-/-, and DKO mice to verify this observation. In contrast to Mochan et al. (2003), we found that neither the absence of MDC1 or 53BP1 alone significantly affected the autophosphorylation at serine 1981 of ATM after IR (Fig. 4 A and Fig. S1, A and B; available at ) even at low doses of IR. Furthermore, there was no significant decrease in ATM phosphorylation in the DKO cells (Fig. 4 A and Fig. S1, A and B). Interestingly, there was some decrease in ATM phosphorylation at a later time point, supporting a possible role of MDC1 in maintaining ATM phosphorylation (Fig. 4 B). However, the loss of both MDC1 and 53BP1 did not further decrease ATM phosphorylation. These results suggest that MDC1 and 53BP1 are not critical for ATM activation.
###end p 25
###begin p 26
###xml 0 90 0 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink">DKO MEFs do not have more severe defects in ATM activation and G2/M checkpoint activation.</bold>
###xml 155 158 155 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 198 201 198 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
DKO MEFs do not have more severe defects in ATM activation and G2/M checkpoint activation. (A and B) ATM, Chk1, and Chk2 activation in wild-type (WT), MDC1-/-, and double knockout (DKO or MDC1/53BP1-/-) MEFs. MEFs of the indicated genotypes were irradiated at the indicated doses and harvested 1 h later (A) or irradiated (2 Gy) and harvested at different time points (B). Cell extracts were then blotted with the indicated antibodies. (C) MEFs were left untreated or irradiated (2 Gy). 1 h later, cells were stained for antiphospho-H3 antibodies, and mitotic populations were determined by FACS. Error bars represent SEM.
###end p 26
###begin p 27
###xml 172 189 172 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">Wang et al., 2002</xref>
###xml 197 216 197 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">Peng and Chen, 2003</xref>
###xml 218 238 218 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">Stewart et al., 2003</xref>
###xml 240 256 240 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">Lou et al., 2006</xref>
###xml 263 266 263 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 276 279 276 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 423 438 423 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, A and B</xref>
###xml 675 678 675 678 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 685 688 685 688 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 929 937 929 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 C</xref>
###xml 1137 1145 1137 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 C</xref>
We also examined how the loss of MDC1 and 53BP1 affects downstream signals of the DDR. MDC1 and 53BP1 have previously been shown to regulate Chk1 and Chk2 phosphorylation (Wang et al., 2002, 2003; Peng and Chen, 2003; Stewart et al., 2003; Lou et al., 2006). MDC1-/- and 53BP1-/- MEFs showed weak activation of Chk1 and Chk2. However, the loss of both MDC1 and 53BP1 did not further decrease Chk1 and Chk2 phosphorylation (Fig. 4, A and B; and Fig. S1 B). Although we did observe a reproducible defect in Chk2 phosphorylation, the decreased level of Chk2 seen in MDC1 KO cells was observed in some, but not all, experiments. Finally, we examined checkpoint activation in MDC1-/-, 53BP1-/-, and DKO MEFs. Both MDC1 and 53BP1 have been shown to regulate the G2/M checkpoint. As has been previously reported, the loss of MDC1 resulted in a defective G2/M checkpoint, with more cells able to enter mitosis after IR than in WT cells (Fig. 4 C). Similarly, the loss of 53BP1 also resulted in some inappropriate progression into mitosis. However, in DKO cells, the observed G2/M checkpoint defect is comparable to that seen in MDC1-null cells (Fig. 4 C). These results suggest that the loss of both 53BP1 and MDC1 does not cause more severe checkpoint defects than the loss of MDC1 alone.
###end p 27
###begin title 28
MDC1 regulates 53BP1 phosphorylation and localization at the sites of DNA damage
###end title 28
###begin p 29
###xml 312 333 312 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">Goldberg et al., 2003</xref>
###xml 335 354 335 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">Peng and Chen, 2003</xref>
###xml 356 376 356 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">Stewart et al., 2003</xref>
###xml 378 404 378 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">Bekker-Jensen et al., 2005</xref>
###xml 454 457 454 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 491 499 491 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 559 562 559 562 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
Our results with 53BP1/MDC1 DKO mice and cells suggest that MDC1 and 53BP1 likely function on the same molecular pathway downstream of ATM. Conflicting results have been reported as to whether 53BP1 foci formation requires MDC1, possibly as a result of the different siRNA used and the extent of MDC1 knockdown (Goldberg et al., 2003; Peng and Chen, 2003; Stewart et al., 2003; Bekker-Jensen et al., 2005). We found that 53BP1 failed to form foci in MDC1-/- cells in response to DNA damage (Fig. 5 A). On the other hand, MDC1 foci formation is normal in 53BP1-/- cells. These results suggest that MDC1 is an upstream regulator of 53BP1 localization after DNA damage.
###end p 29
###begin p 30
###xml 0 56 0 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MDC1 regulates 53BP1 foci formation and phosphorylation.</bold>
###xml 221 224 217 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 233 236 229 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
MDC1 regulates 53BP1 foci formation and phosphorylation. (A-C) MEFs of the indicated genotypes were irradiated (10 Gy), and foci formation of MDC1, 53BP1, RNF8, and gammaH2AX was determined by immunofluorescence. (D) MDC1+/+ and MDC1-/- MEF cells were irradiated (2 Gy), and, 1 h later, 53BP1 was immunoprecipitated and blotted with the indicated antibodies. (E) Proposed model of the regulation of 53BP1 phosphorylation and localization by MDC1. Bars, 10 muM.
###end p 30
###begin p 31
###xml 225 242 225 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">Huen et al., 2007</xref>
###xml 244 262 244 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">Kolas et al., 2007</xref>
###xml 264 284 264 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">Mailand et al., 2007</xref>
###xml 286 308 286 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">Wang and Elledge, 2007</xref>
###xml 354 357 354 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 390 393 390 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 507 515 507 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 B</xref>
###xml 579 587 579 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 C</xref>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 394 398 <span type="species:ncbi:10090">mice</span>
Recent studies suggest that MDC1 might regulate the localization of DNA damage factors through the E3 ubiquitin ligase RNF8, which ubiquitinates H2AX and creates binding sites for downstream factors, such as BRCA1 and 53BP1 (Huen et al., 2007; Kolas et al., 2007; Mailand et al., 2007; Wang and Elledge, 2007). To confirm these studies, we generated RNF8-/- mice and isolated MEFs from RNF8-/- mice. Loss of RNF8 resulted in the failure of 53BP1 foci formation, whereas MDC1 foci formation remained intact (Fig. 5 B). On the other hand, RNF8 foci formation is dependent on MDC1 (Fig. 5 C), suggesting the existence of an MDC1-RNF8-53BP1 pathway for the accumulation of 53BP1 at or near the sites of DNA damage.
###end p 31
###begin p 32
###xml 273 291 273 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">Munoz et al., 2007</xref>
###xml 306 314 306 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 D</xref>
###xml 368 371 368 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
We further investigated whether MDC1 regulates 53BP1 phosphorylation. 53BP1 is phosphorylated at S25/29 by ATM after DNA damage, and the phosphorylation of S25 has been shown to be important for the binding of Pax transactivation domain-interacting protein and proper DDR (Munoz et al., 2007). As shown in Fig. 5 D, 53BP1 phosphorylation at S25/29 is defective in MDC1-/- cells, suggesting that MDC1 also regulates 53BP1 phosphorylation after DNA damage. Collectively, our results suggest that MDC1 and 53BP1 act in the same molecular pathway of the DDR, and MDC1 is an upstream regulator of 53BP1 by regulating 53BP1 phosphorylation and foci formation after DNA damage.
###end p 32
###begin p 33
###xml 124 127 124 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 182 185 182 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 476 480 476 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid</italic>
###xml 486 489 486 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 560 564 560 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid</italic>
###xml 573 576 573 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 583 602 583 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">Essers et al., 2000</xref>
###xml 710 726 710 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">Xie et al., 2007</xref>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 186 190 <span type="species:ncbi:10090">mice</span>
###xml 399 403 <span type="species:ncbi:10090">mice</span>
###xml 447 451 <span type="species:ncbi:10090">mice</span>
###xml 490 494 <span type="species:ncbi:10090">mice</span>
###xml 577 581 <span type="species:ncbi:10090">mice</span>
MDC1 and 53BP1 are two important mediator proteins of the DDR pathway. Our observations indicate that the phenotypes of MDC1-/- and DKO mice are substantially milder than that of ATM-/- mice, suggesting that it is unlikely that MDC1 and 53BP1 are critical for ATM activation. Concurrently, our studies of DDR (radiosensitivity, DNA repair, and genomic stability) indicate that the phenotypes of DKO mice and cells mostly resemble those of MDC1 KO mice; this is in contrast to scid/Rad54-/- mice that showed a drastic increase in radiosensitivity compared with scid or Rad54-/- mice (Essers et al., 2000). Although a role in nonhomologous end joining and HR by 53BP1 and MDC1, respectively, has been suggested (Xie et al., 2007), it is possible that 53BP1 and MDC1 only play a supporting role in these processes, which were not obvious in our in vivo studies.
###end p 33
###begin p 34
###xml 367 370 367 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 379 382 379 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 706 723 706 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">Huen et al., 2007</xref>
###xml 725 743 725 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">Kolas et al., 2007</xref>
###xml 745 765 745 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">Mailand et al., 2007</xref>
###xml 767 789 767 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">Wang and Elledge, 2007</xref>
###xml 1019 1035 1019 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">Kim et al., 2007</xref>
###xml 1037 1057 1037 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">Sobhian et al., 2007</xref>
###xml 1059 1076 1059 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">Wang et al., 2007</xref>
###xml 1363 1371 1363 1371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 E</xref>
###xml 1590 1593 1590 1593 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1629 1632 1629 1632 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
We have shown that MDC1 regulates 53BP1 localization to the sites of DNA damage and 53BP1 phosphorylation at S25/29, which is necessary for the correct phosphorylation of both Chk2 and BRCA1 and subsequent checkpoint activation. Therefore, MDC1 might regulate these signaling events partially through its ability to control 53BP1 phosphorylation. Using MEFs from MDC1-/- and RNF8-/- mice, we show that 53BP1 localization to the sites of DNA damage requires RNF8, which, in turn, requires MDC1. These results support several recent studies demonstrating that MDC1 recruits RNF8 to the sites of DNA damage and RNF8, in turn, ubiquitinates H2AX, H2A, and probably other substrates at the sites of DNA breaks (Huen et al., 2007; Kolas et al., 2007; Mailand et al., 2007; Wang and Elledge, 2007). Ubiquitinated H2AX, H2A, or other RNF8 substrates would then recruit BRCA1 and 53BP1. BRCA1 is proposed to bind ubiquitinated RNF8 substrates indirectly through a mediator protein, Rap80, which has an ubiquitin-binding domain (Kim et al., 2007; Sobhian et al., 2007; Wang et al., 2007). However, Rap80 is not required for 53BP1 foci formation, suggesting that an unidentified factor mediates the binding of ubiquitinated protein and 53BP1. Therefore, we propose an H2AX-MDC1-RNF8 pathway, which is distinct from methylated H3/H4 that also regulates 53BP1 foci formation (Fig. 5 E). It is not clear why cells use two different mechanisms to regulate the localization of 53BP1 and whether these two mechanisms relate to each other. The fact that 53BP1 but not MDC1 is essential for CSR and that 53BP1-/- cells respond differently from MDC1-/- cells to MMC suggest that 53BP1 does have functions independent of MDC1. It is possible that the mode of 53BP1 recruitment is specific to the functions of 53BP1. These issues need to be further clarified in the future.
###end p 34
###begin p 35
###xml 286 303 286 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">Ward et al., 2003</xref>
###xml 305 325 305 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">Morales et al., 2006</xref>
###xml 561 582 561 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">Bartkova et al., 2007</xref>
###xml 876 897 876 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">Bartkova et al., 2007</xref>
###xml 280 284 <span type="species:ncbi:10090">mice</span>
###xml 553 559 <span type="species:ncbi:9606">humans</span>
###xml 641 646 <span type="species:ncbi:9606">human</span>
###xml 774 778 <span type="species:ncbi:10090">mice</span>
###xml 854 859 <span type="species:ncbi:9606">human</span>
Our studies on organism development and tumorigenesis further highlight the fact that genomic instability is a driving force of tumorigenesis, supporting the data that many DDR factors function as potent tumor suppressors. 53BP1 has been show to function as a tumor suppressor in mice (Ward et al., 2003; Morales et al., 2006), whereas our data are the first to suggest a role for MDC1 in tumor suppression. A recent study showed the loss of MDC1 expression in breast and lung cancer samples, supporting a potential role of MDC1 in tumor suppression in humans (Bartkova et al., 2007). However, MDC1 mutations have not yet been identified in human cancer samples. We did not find that loss of both MDC1 and 53BP1 significantly increased tumor incidence compared with MDC1 KO mice. Interestingly, the loss of MDC1 and 53BP1 is mostly mutually exclusive in human cancer samples (Bartkova et al., 2007). These results indicate that the loss of either MDC1 or 53BP1 is sufficient for tumorigenesis, and the loss of both does not provide an overt additional advantage for tumor formation. Collectively, our studies clearly establish MDC1 as a tumor suppressor and an upstream regulator of 53BP1 in the DDR pathway.
###end p 35
###begin title 36
Materials and methods
###end title 36
###begin title 37
###xml 29 33 <span type="species:ncbi:10090">mice</span>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Generation of 53BP1/MDC1 DKO mice, RNF8-deficient mice, and MEFs
###end title 37
###begin p 38
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 21 37 21 37 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">Lou et al., 2006</xref>
###xml 59 62 59 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 74 91 74 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">Ward et al., 2003</xref>
###xml 110 113 110 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 118 121 118 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 189 192 189 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 216 219 216 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 224 227 224 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 15 19 <span type="species:ncbi:10090">mice</span>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 284 288 <span type="species:ncbi:10090">Mice</span>
###xml 348 352 <span type="species:ncbi:10090">mice</span>
###xml 408 412 <span type="species:ncbi:162683">Mayo</span>
MDC1+/- female mice (Lou et al., 2006) were bred with 53BP1-/- male mice (Ward et al., 2003) to generate 53BP1+/- MDC1+/- offspring. Double heterozygous females were then bred back to 53BP1-/- males to generate 53BP1-/- MDC1+/- offspring, which were used for all subsequent breeding. Mice were observed daily for signs of poor health, and moribund mice were killed and screened for tumors in accordance with Mayo Foundation Institutional Animal Care and Use Committee guidelines.
###end p 38
###begin p 39
###xml 170 174 170 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RNF8</italic>
###xml 277 281 277 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RNF8</italic>
###xml 640 643 640 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 722 725 722 725 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 747 750 747 750 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 554 559 <span type="species:ncbi:10090">mouse</span>
###xml 580 584 <span type="species:ncbi:10090">mice</span>
###xml 621 625 <span type="species:ncbi:10090">mice</span>
###xml 644 648 <span type="species:ncbi:10090">mice</span>
###xml 726 730 <span type="species:ncbi:10090">mice</span>
###xml 751 755 <span type="species:ncbi:10090">mice</span>
For the generation of RNF8-deficient mice, two embryonic stem cell lines, RRR260 and PT238, were purchased from Bay Genomics. In the RRR260 embryonic stem cell line, the RNF8 gene was disrupted by a neo gene selection cassette inserted between transcripted exon 4 to exon 5 of RNF8. In the PT238 cell line, a neo cassette was inserted between transcripted exon 5 to exon 6. The exact insertion sites were mapped by genomic PCR and DNA sequencing. Both embryonic stem cell lines were injected into C57BL/6 blastocysts to generate two independent chimeric mouse lines. The chimeric mice were then crossed back with C57BL/6 mice to obtain RNF8+/- mice, which were used for subsequent breeding to generate two independent RNF8-/- mice lines. Both RNF8-/- mice lines show identical phenotypes. All MEFs were generated from embryonic day 13.5 or 14.5 embryos using standard procedures.
###end p 39
###begin title 40
Metaphase spreads
###end title 40
###begin p 41
###xml 96 98 96 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
Passage 1 MEFs were left unirradiated or were treated with 1 Gy and then incubated with 50 ng ml-1 colcemid for 3-4 h. Cells were collected, washed with PBS, resuspended in 75 mM KCl, and incubated at room temperature for 15 min. Cells were fixed in Carnoy's solution (75% methanol and 25% acetic acid), and 15-mul aliquots were dropped onto slides and stained with 5% Giemsa solution. Metaphase spreads were observed using a microscope (Eclipse 80i; Nikon) with a 40x NA 1.3 oil objective lens at room temperature. Spreads were photographed and analyzed using a camera (Spot 2 Megasample; Diagnostic Instruments, Inc.) and Spot software 4.6 (Diagnostic Instruments, Inc.).
###end p 41
###begin title 42
Immunofluorescence
###end title 42
###begin p 43
###xml 168 172 <span type="species:ncbi:9925">goat</span>
Cells were washed with PBS, incubated in 3% PFA for 12 min, and permeabilized in 0.5% Triton X-100 solution for 5 min at room temperature. Samples were blocked with 5% goat serum and incubated with primary antibody for 60 min. Samples were washed and incubated with secondary antibody (FITC and rhodamine labeled) for 60 min. Cells were then stained with DAPI to visualize nuclear DNA. The coverslips were mounted onto glass slides with antifade solution and visualized using an Eclipse 80i fluorescence microscope with a 60x NA 1.3 oil objective lens at room temperature. Spreads were photographed and analyzed using a Spot 2 Megasample camera and Photoshop software (Adobe).
###end p 43
###begin title 44
Western blotting
###end title 44
###begin p 45
###xml 227 232 <span type="species:ncbi:10090">mouse</span>
Cell lysates were prepared and Western blots were performed using standard protocols. Phospho-ATM antibodies were obtained from Rockland, and Chk1 and phospho-Chk1 antibodies were purchased from Cell Signaling Technology. Anti-mouse ATM antibodies were generously provided by Y. Shiloh (Tel Aviv University, Tel Aviv, Israel).
###end p 45
###begin title 46
The G2/M checkpoint assay
###end title 46
###begin p 47
Cells were irradiated (2 Gy) and were harvested 1 h later. Cells were then fixed and stained with antiphospho-H3 antibodies (Cell Signaling Technology). Mitotic population (mitotic index) was determined by FACS analysis.
###end p 47
###begin title 48
Online supplemental material
###end title 48
###begin p 49
Fig. S1 shows that DKO MEFs do not have more severe defects in the ATM-dependent DNA damage signaling pathway. Online supplemental material is available at .
###end p 49
###begin title 50
Supplementary Material
###end title 50
###begin title 51
[Supplemental Material Index]
###end title 51
###begin p 52
###xml 76 80 <span type="species:ncbi:162683">Mayo</span>
The authors would like to thank Susanna Stevens (Division of Biostatistics, Mayo Clinic, Rochester, MN) for her assistance with statistical analyses and Xiaochun Yu for initiating the RNF8 KO project.
###end p 52
###begin p 53
###xml 357 361 <span type="species:ncbi:162683">Mayo</span>
This work was supported, in part, by grants from the National Institutes of Health (to J. Chen). Z. Lou was supported by a Susan G. Komen Breast Cancer Foundation research grant. M.S.Y. Huen is supported by an Anna Fuller postdoctoral fellowship. J. Chen is a recipient of an Era of Hope Scholars Award from the Department of Defense and is a member of the Mayo Clinic Breast Specialized Program of Research Excellence program.
###end p 53

